Listeria monocytogenes is widely used as a model to study immune responses against intracellular bacteria. It has been shown that neutrophils and macrophages play an important role to restrict bacterial replication in the early phase of primary infection in mice, and that the cytokines interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) are essential for protection. However, the involved signaling pathways and effector mechanisms are still poorly understood. This study investigated mouse strains deficient for the IFN-dependent transcription factors interferon consensus sequence binding protein (ICSBP), interferon regulatory factor (IRF)1 or 2 for their capacity to eliminate Listeria in vivo and in vitro and for production of inducible reactive nitrogen intermediates (RNI) or reactive oxygen intermediates (ROI) in macrophages. ICSBP−/− and to a lesser degree also IRF2−/− mice were highly susceptible to Listeria infection. This correlated with impaired elimination of Listeria from infected peritoneal macrophage (PEM) cultures stimulated with IFN-γ in vitro; in addition these cultures showed reduced and delayed oxidative burst upon IFN-γ stimulation, whereas nitric oxide production was normal. In contrast, mice deficient for IRF1 were not able to produce nitric oxide, but they efficiently controlled Listeria in vivo and in vitro. These results indicate that (a) the ICSBP/IRF2 complex is essential for IFN-γ–mediated protection against Listeria and that (b) ROI together with additional still unknown effector mechanisms may be responsible for the anti-Listeria activity of macrophages, whereas IRF1-induced RNI are not limiting.

Listeria monocytogenes, a grampositive facultative intracellular bacterium, infects macrophages and hepatocytes in mice and has been used as a classic model to study immune responses against intracellular bacteria (1). Neutrophile granulocytes (2), γδ T cells (3), and above all macrophages (4) are important during the early phase of the immune response. In SCID mice lacking mature B and T lymphocytes, NK cells activated by macrophage-derived TNF-α have been shown to activate the listericidal effector mechanisms of macrophages via secretion of IFN-γ (5). These cells are able to restrict initial replication of Listeria in murine liver and spleen, since IFN-γ inhibits evasion of Listeria from phagosomes into the cytoplasm (6). Specific T cells are needed for final elimination of the pathogen (7) and also for protection against secondary infection (810). Studies of Listeria infection in mice deficient for IFN-γ (11), IFN-γ receptor (12) or TNF receptor 1 (13) have shown that the two cytokines IFN-γ and TNF-α are crucial for survival. However, the involved signaling pathways are not known, and the effector mechanisms used by macrophages for killing of Listeria are still debated. The role of reactive oxygen intermediates (ROI)1 (1419) as well as reactive nitrogen intermediates (RNI) (2023) has been analyzed repeatedly; these experiments revealed variations between different experimental setups and analyzed species.

Much information has accumulated about molecular and in vivo biological function of IFNs over the past 15 years (for review: see 24, 25). Two different pathways can be distinguished: IFN-α and -β are binding to the type I IFN receptor, whereas IFN-γ binds to the type II IFN receptor. Analysis of gene-targeted mice deficient for only one (12, 26) or both of these receptors (27) have revealed that depending upon the type of the pathogen these two systems are either redundant or complementary in their antimicrobial activity (for review see 28).

A variety of IFN-induced transcription factors have now been described, most of them belonging to the structurally related family of the interferon regulatory factors (IRFs) and some being identical with signal transducers and activators of transcription (STATs; Table 1). It has been revealed that there is an overlap between the two IFN systems at the level of transcription. Whereas some components of the interferon-stimulated gene factor (ISGF) 3α are only induced by type I IFN (29), IRF1 (30, 31) and STAT1 (32, 33) can be upregulated via both IFN receptors or by viruses directly (31), and interferon consensus sequence binding protein (ICSBP) is the prototype of a type II IFN-induced factor (34, 35). IRF2 is omitted from Table 1, because the way of its induction has not been clearly elucidated so far. The fact that IRF2 is lacking in ICSBP −/− mice (36) suggests induction via IFN-γ pathway. In vitro transfection systems with reporter genes have revealed that IRF1 (37) and ISGF3 (29) are activating transcription of genes containing the interferon-stimulated response element (ISRE) in their promotor sequence, whereas ICSBP (38) and IRF2 (37) have repressor activity for ISRE-containing genes.

The generation of gene-targeted mice for the transcription factors IRF1 (39, 40), IRF2 (39) and ICSBP (36) allows to test for their biological role and their induction in different infectious disease models, especially for activation of macrophages. This study therefore evaluated the susceptibility of these mouse strains to Listeria infection in vivo and compared it to some macrophage effector functions upon IFN-γ stimulation in vitro.

Materials And Methods

Mice.

Mice deficient for ICSBP (background C57BL6× 129Sv), IRF1(129Sv), IRF2 (C57BL/6), IFN I and II receptor (both 129Sv) were generated by gene targeting in embryonic stem cells as described (12, 26, 36, 39). IRF1-deficient mice were kindly provided by Prof. Charles Weissmann (Institute for Molecular Biology I, University of Zürich, Switzerland). IFN type I receptor−/− (A129) and IFN type II receptor−/− (G129) mice were obtained from the breeding colony of Prof. M. Aguet (Institute for Molecular Biology I, University of Zürich, Switzerland). Control C57BL/6 or 129Sv mice as well as RAG2−/− mice were obtained from the Institute for Laboratory Animals (Veterinary Hospital, Zürich, Switzerland). Mice were used at 6–10 wk of age. The different breedings (except A129 and G129) and all the experiments were performed under conventional (non-SPF) conditions.

Listeria Culture and Infection.

Listeria monocytogenes was originally obtained from B. Blanden (Canberra, Australia). It was cultured in trypticase soy broth (BBL Microbiology Systems, Cockeysville, MD), and overnight cultures were titrated on tryptose blood agar plates (Difco Laboratories, Detroit, MI). For injection, the original culture was diluted in BSS to inject the indicated dose in 200 μl for i.v. or 30 μl for injection into the footpad (i.f.).

Determination of Bacterial Titers.

On the indicated days after infection the whole spleen and one lobe of the liver were taken out and homogenized. Bacterial titers were determined by plating out four serial 10-fold dilutions of organ suspensions on tryptose blood agar plates.

Adoptive Transfer of Spleen Cells.

On day 0, spleen single cell suspensions were let to adhere to plastic to deplete them from macrophages. After 2 h 3 × 107 splenocytes were transferred into nonirradiated RAG2−/− recipients. On day 1 the recipients were infected with 2 × 105 CFU of Listeria, and on day 10 liver and spleen were taken out to determine bacterial titers.

Peritoneal Macrophage Cultures.

Peritoneal macrophages (PEM) of different strains were elicited by injection of 2 ml of a starch solution (2%; Merck, Darmstadt, Germany) intraperitoneally on day −5 and harvested on day 0 by rinsing the peritoneal cavity with 10 ml of cold BSS. The macrophages were washed three times with BSS supplemented with albumin to prevent clumping and then plated on cover slips in 24-well plates. Cells were cultured in IMDM (Gibco, Basel, Switzerland) supplemented with 10% FCS, glutamine, and 50 μg/ml gentamicin, an only extracellularly effective antibiotic. After 2 h of adherence the cover slips were washed twice and put in 1 ml IMDM. The cultures were stimulated with 200 ng/ml LPS, with 200 U/ml recombinant murine IFN-γ (Genzyme, Cambridge, MA) or a combination of both for 42 h and then used for determination of nitric oxide (NO) production, of respiratory burst or of Listeria killing in vitro. In those cultures used for killing assays, the medium was changed to antibiotic-free after 24 h.

Determination of NO and Respiratory Burst.

NO production was measured by determination of nitrite accumulation in PEM cultures with Griess reagent (0.05% N-1-naphthyl-ethylene-diamine-dihydrochloride/0.5% sulfanilamide/2.5% phosphoric acid; all from Fluka, Buchs, Switzerland) as described (41). In brief, 50 μl cell culture supernatant was added to 150 μl Griess reagent in 96well plates and incubated at room temperature for 10 min. Absorption was read with an ELISA reader at 570 and 630 nm.

Respiratory burst was measured as H2O2 production by cultured PEM upon PMA (Sigma, Buchs, Switzerland) stimulation as described (18). In brief, H2O2 secretion of macrophages was quantified by chemiluminescence under presence of horseradish peroxidase type I (Sigma) and 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol; Sigma) after triggering with 50 ng/ml PMA. Light emission was discontinuously measured over 15 min in a LKB 1251 luminometer (LKB, Bromma, Sweden). Values in mV were converted into pmol H2O2 after calibration by the scopoletin method (42). The cells on the cover slips were counted, and values for NO and H2O2 calculated as nmol/105 cells. In Fig. 4 B stimulation index of stimulated versus unstimulated cultures is shown, because absolute values of respiratory burst varied between the experiments. PMA was used to trigger respiratory burst because, as a chemically defined substance, it is the most reliable burst trigger. Also opsonized Listeria, BCG or zymosan could be used with similar capacities to trigger burst (23, 43), but more variability. Because we investigated mouse strains deficient for various IFNdependent transcription factors, the induction phase of NADPH oxidase during 2 d under IFN-γ stimulation is important in our experiment, whereas the effector phase of the burst trigger is only used as read-out to measure the enzyme activity by providing the best stimulator (PMA) and eccess of substrate (luminol).

In Vitro Killing Assay.

PEM cultures in antibiotic-free medium as described above were infected with 107 CFU of Listeria from an overnight culture, washed three times and opsonized with normal human serum. After 15 min of phagocytosis the infected cultures were washed thoroughly, and gentamicin-containing medium and the respective stimulators were added. To determine the infection rate at time point t0, three cover slips were taken out. The remaining ones were further cultured for 7 h to allow digestion of Listeria by macrophages. After 7 h the cover slips were taken out, dried, and then stained according to May-Grünwald-Giemsa. For each mouse strain and each stimulation a total of 600 macrophages were counted under the microscope to determine the number of Listeria-infected cells. The change of infected macrophages was calculated in percentage of the infection rate at t0. For details, see reference 18.

Immunohistochemistry.

Mice infected with 5 × 103 CFU of Listeria i.v. were sacrificed on day 5 or 6. Organs were immersed in Hank's BSS and frozen in liquid nitrogen. 5-μm cryosections were fixed with acetone for 10 min, immunostained for Listeria with a polyclonal rabbit anti-Listeria serum (diluted 1/2,000; kindly provided by Professor J. Bille, Institute of Microbiology, University Hospital of Lausanne, Switzerland) and for iNOS with a polyclonal rabbit anti-iNOS serum (diluted 1/1,500; Biomol, Plymouth, PA). Bound primary antibodies were detected using a sandwich staining procedure. Sections were incubated with alkaline phosphatase-labeled goat anti–rabbit Ig (diluted 1/80; Jackson Laboratories, Bar Harbor, Maine) followed by alkaline phosphataselabeled donkey anti–goat Ig (diluted 1/80; Tago). Dilutions of secondary reagents were made in TBS containing 5% normal mouse serum. All incubation steps were done for 30 min at room temperature. Alkaline phosphatase was visualized using naphthol ASBI phosphate and New Fuchsin (Sigma) as substrate, which yields a red color reaction product. Endogenous alkaline phosphatase was blocked by levamisole. Sections were counterstained with hemalum, and cover slips were mounted with glycerol/gelatin.

Results

Enhanced Bacterial Replication and Increased Lethality after Listeria Monocytogenes Infection in ICSBP-deficient Mice.

Gene targeted mice deficient for ICSBP, IRF1, or IRF2 were infected with various doses of Listeria intravenously or peripherally i.f., and survival was monitored daily (Table 2). All ICSBP−/− mice died after injection of a dose as low as 50 CFU of Listeria, whereas five of six IRF2−/− mice succumbed to a dose of 5 × 103 CFU within 12 d. In contrast, IRF1−/− and wild-type mice resisted to a dose of 5 × 103 CFU injected intravenously. However, IRF1−/− mice on C57BL/6 background and held under strict SPF conditions also showed enhanced susceptibility to Listeria, when injected with a 5–10-times higher dose intraperitoneally (Ferrick, D., and H.W. Mittrücker, personal communication). Listeria titers in liver and spleen were determined 24 h after a high dose (2 × 105 CFU) and 5 d after an intermediate dose (5 × 103 CFU) of Listeria injected intravenously. In the first 24 h, when neutrophils seem to play an important role (2), there was almost no titer difference between the three strains and only a 10-fold difference compared to control mice (data not shown). However, after 5 d when activated macrophages are essential for control of Listeria infection, ICSBP−/− and IRF2−/− showed between 102- and 106-fold higher titers in liver and spleen, whereas IRF1−/− mice controlled Listeria replication comparable to controls (Fig. 1 A). In vitro gene regulation studies have revealed that ICSBP and IRF2 form complexes which then have a markedly enhanced DNA binding capacity to ISRE compared to the single factors (44). In contrast to IRF1, they are both negative regulators of classical IFN-induced genes. However, both transcription factors are obviously of major importance for early anti-Listeria immune responses. Since it has been shown that ICSBP−/− mice do not express IRF2 (although the gene is intact [36]), this can explain the even more drastic phenotype of ICSBP−/− compared to IRF2−/− mice, because they represent functionally a double knock-out phenotype.

Competition of different transcription factors of the IRF family at the DNA binding level has been demonstrated in in vitro studies (45). It was therefore possible that lack of IFN type I–induced transcription factors would lead to increased activity of IFN type II–induced factors. To test this in vivo, we infected mice deficient for the type II (G129) or the type I (A129) IFN receptor and control mice (wt129) with 5 × 103 CFU of Listeria and determined bacterial titers in liver and spleen on day 5 (Fig. 1,B). As demonstrated earlier (12), G129 mice showed drastically enhanced bacterial replication and lethality (Table 2), whereas A129 eliminated the pathogen even more efficiently than wt129 mice. This result suggests that competition between the two signaling pathways at the transcription factor level occurs. IFN type II–induced transcription factors (and among them especially ICSBP) may compensate for the lack of IFN type I–induced factors in the A129 mouse, thereby conferring even higher resistance to Listeria infection than in control mice. Because early Listeria clearance in nude mice (46) has been shown to be more efficient than in immunocompetent controls because their macrophages are preactivated (probably by LPS derived from normal intestinal bacteria leaking into circulation), this may be an additional factor explaining the results in A129 mice and also the difference between IRF1−/− mice held under conventional versus SPF conditions.

Capacity of Adoptively Transferred ICSBP/− Spleen Cells to Correct Immunodeficiency of RAG2/− Mice.

Our results of anti-Listeria immune response in ICSBP−/− mice suggested a major defect of IFN-γ-induced macrophage function, because lymphocytes, especially cytotoxic T cells, but also B cells, had been shown to function almost normally after viral infections (36, 39). Therefore macrophage functions were tested in vivo by adoptive transfer experiments and in vitro by PEM cultures.

RAG2−/− mice are devoid of functional T and B cells, but have normal macrophages and natural killer cells (47). When infected with an intermediate dose of Listeria, they are able to control bacterial replication comparable to nude mice (46), but cannot eliminate the pathogen. To test whether ICSBP-deficient T cells could develop normal specific anti- Listeria immunity, we transferred on day 0 macrophage- depleted ICSBP−/− spleen cells into RAG2−/− mice, challenged them with a high dose of Listeria (2 × 105 CFU i.v.) on day 1 and evaluated Listeria titers in liver and spleen on day 10 to look for efficiency of the specific immune response. As a positive control normal spleen cells and as a negative control no spleen cells were transferred. The result (Fig. 2) revealed no difference of Listeria counts between recipients of ICSBP−/− and ICSBP+/+ spleen cells; in contrast RAG2−/− mice that did not receive spleen cells exhibited 100- (spleen) to 1,000-fold (liver) higher bacterial counts. This result indicates that ICSBP−/− splenocytes (especially the mutant T cells) were able to promote elimination of Listeria as successfully as normal lymphocytes in cooperation with the intact macrophage compartment of the RAG2−/− mouse.

Analysis of Listeria Killing in an In Vitro PEM Culture.

To evaluate listericidal activity of macrophages of the different mutant mouse strains, we tested PEM in an in vitro killing assay. ICSBP−/−, IRF1−/−, and IRF2−/− PEM were elicited by starch injection intraperitoneally, plated onto cover slips and cultured as described in Materials and Methods. After 42 h the cultures were infected with Listeria in vitro, and the number of infected cells determined at time point t0 and after 7 h of infection. The results (Fig. 3) show that PEM of ICSBP−/− and, to a lesser degree, IRF2−/− mice allowed enhanced replication of Listeria, whereas PEM of IRF1−/− and normal mice were able to reduce the bacterial load in these macrophage cultures. Also the number of bacteria per macrophage was higher in ICSBP−/− mice (mostly more than 10 bacteria/cell) compared to their controls (0–4 bacteria/cell), revealing some macrophages with plenty of Listeria and typical comet tails (18). This finding confirms the defect in macrophage effector function, which correlates with the in vivo susceptibility of these mouse strains to Listeria (ICSBP−/− >IRF2−/− >IRF1−/−).

Evaluation of NO Synthesis and Respiratory Burst as AntiListeria Effector Functions of Macrophages.

The effector mechansim responsible for listericidal properties of macrophages is widely studied and still not clearly defined. ROI (1419) as well as RNI (2023) have been proposed to be of major importance. Therefore NO production (measured as nitrite accumulation in culture medium) and respiratory burst upon PMA stimulation (H2O2 production measured by chemiluminescence) were tested in PEM cultures stimulated with LPS and/or IFN-γ as described in Materials and Methods. NO production (Fig. 4,A) was absent in IRF1−/− mice confirming earlier results that iNOS cannot be induced by IFN type I or II combined with LPS and/or TNF in the absence of IRF1 (48, 49). In contrast, iNOS activity was normal in ICSBP−/− and in IRF2−/− mice as well as in G129 mice (50). This finding in IRF2−/− mice differs from recently published results (51). The high susceptibility of the ICSBP−/− and G129 strains to Listeria infection in vivo and in vitro indicates that the NO effector mechanism does not play a limiting role in Listeria clearance. The phenotype of IRF1−/− mice found here is compatible to the published results of Listeria infection in iNOS-deficient mice (23). These mice showed also a slightly enhanced bacterial replication (10–100-fold) and a higher lethality to Listeria infection, but only after injection of 6 × 104 CFU i.v. The LD50 of iNOS-deficient mice was only a factor 10 lower compared to their normal littermates, whereas in the case of ICSBP−/− mice this difference is more than 10,000fold (Table 1; LD50 for C57BL/6 mice is ∼3 × 105 CFU [52]). The fact that iNOS induction in the susceptible strains (ICSBP−/−, IRF2−/−) was higher than in controls (Figs. 4,A, and 5) could even indicate that NO may have a toxic effect on infected cells during murine listeriosis.

With respect to respiratory burst upon PMA challenge, all mouse strains showed comparable basal activity of unstimulated cultures; however, in ICSBP−/− and IRF2−/− mice ROI production could not be stimulated by IFN-γ (Fig. 4 B) and was 3–5 min delayed compared to control mice (data not shown). This finding suggests that deficient ROI production might be partially responsible for the high susceptibility of ICSBP−/− mice to Listeria, but it cannot fully explain the drastic phenotype of these mice. At least a third effector pathway not yet known may have to be evoked to explain this phenotype (see Discussion). In addition, the fact that LPS-induced respiratory burst was enhanced in IRF2−/− mice correlates inversely with a recently published finding of high IRF2 levels in LPS-hyporesponsive mouse strains (53). Thus, IRF2 may mediate the macrophage deactivating effect of LPS (42).

Expression of iNOS in Liver and Spleen after Listeria Infection of ICSBP/− and IRF2/− Mice, but not of IRF1/− Mice.

Apart from macrophages hepatocytes are a major target cell in murine listeriosis. They are infected by direct cell-to-cell spread of the pathogen that is able to associate with actin filaments of the cytoskeleton (54). Hepatocytes can produce NO. Therefore, to see whether the phenotype of ICSBP−/− and IRF2−/− mice is due to a localized inability of iNOS expression in the liver, immunohistological analysis of iNOS expression in liver (Fig. 5) and spleen (not shown) after Listeria infection was performed. Mice of the three gene-targeted and control strains were infected with Listeria (5 × 103 CFU i.v.). On day 5 or 6 liver and spleen were taken, cryosectioned, and then immunostained for Listeria and for iNOS with an appropriate polyclonal rabbit antiserum. Induction of iNOS comparable to wild-type mice could be demonstrated in all strains except IRF1−/− (Fig. 5, C, F, K, M, O). It was abundant in regions where Listeria and abcesses were found (detail shown in Fig. 5, G and H). In addition fulminant Listeria proliferation in liver (Fig. 5,E) and spleen of ICSBP−/− mice was found with accompanying tissue destruction (Fig. 5,D) correlating with the high bacterial titers (Fig 1). This analysis also shows that the susceptibility of ICSBP−/− and IRF2−/− mice to Listeria is not due to inefficient NO production in the liver. In contrast, IRF1−/− mice were well protected and did not express iNOS in the liver. This cannot be explained by earlier decline of the bacterial load because these mice had equal Listeria titers in the liver as wild-type mice 5 d after infection (Fig. 1 A). The same analysis was performed on spleen sections with comparable results (not shown).

Discussion

The type II IFN system has been shown to be of crucial importance for immunity against Listeria, because mice deficient for IFN-γ (11) or the type II IFN receptor (12) are highly susceptible to this bacterium. However, the intracellular signalling pathway and the final effector mechanisms involved in Listeria clearance are only incompletely understood. The presented analysis of three gene-targeted mouse strains deficient of ICSBP, IRF1, or IRF2 with respect to their capacity to survive and eliminate Listeria in vivo and in vitro and to the ability of their macrophages to respond with ROI or RNI production upon IFN-γ stimulation suggests three major conclusions: (a) ICSBP/IRF2 complex (but not IRF1) is of crucial importance for murine innate immunity to Listeria in vivo and in vitro, (b) iNOS induction and NO synthesis play no limiting role for anti- Listeria activity of macrophages upon IFN-γ stimulation, (c) stimulation of ROI production by IFN-γ together with a postulated third yet unknown effector pathway in macrophages may be responsible for protection in the early phase of primary Listeria infection. The role of NO for antimicrobial activity of macrophages has been tested in other infectious model systems. It seems to play an important role in leishmaniasis (55, 56) and tuberculosis (48), but has no limiting effect in toxoplasmosis (57) and listeriosis (this study, references 58, 59).

Our results of the analysis of mice deficient for IFN type I or II receptors revealed surprisingly that the type I IFN receptor-deficient mice (A129) were better protected than their normal littermates. This finding may reveal in vivo competition of transcription factors of both signaling pathways at the DNA binding level (45) suggesting that absence of the type I system enhances function of the type II system and concurrently Listeria protection. A potentiating effect of LPS leaking through from intestinal bacteria leading to macrophage preactivation may be involved.

From the analysis of TNF receptor 1-deficient (13) mice it is known that TNF-α is a second important cytokine for protection against Listeria. It is produced by macrophages upon infection with Listeria and may act via the following two pathways: (a) the SCID model revealed that TNF-α is necessary for activation of NK cells that then produce IFN-γ to further induce TNF receptor 1 and TNF-α expression (60, 61) and macrophage effector functions (4); (b) macrophage- or γδ T cell–derived TNF-α may act in an autocrine or paracrine fashion directly on macrophages to activate anti-Listeria effector molecules. Involvement of the ICSBP/ IRF2 complex in the signaling cascade of the TNF receptor could theoretically explain the described in vivo findings, but this has not been formally demonstrated so far. In addition, another transcription factor, NF-IL6, which can be upregulated by LPS/CD14 and also by TNF-α (62), is important for clearance of Listeria as demonstrated in the NF-IL6–deficient mice (63).

From our findings in three different mouse strains and from the published literature, the following model of signaling events in activation of anti-Listeria immunity may be proposed (Fig. 6): after activation of IFN receptors various tyrosine kinases are induced and STAT proteins phosphorylated (Table 1); they regulate the induction and activation of transcription factors of the IRF family among which the exclusively IFN-γ-dependent ICSBP mediates protection against Listeria. Two major questions remain open: (a) What molecules are involved in the signalling of the TNF receptor that could explain its importance for anti-Listeria immunity (ICSBP, NF-IL6, other transcription factors, indirect effect via NK cell activation)? (b) How do macrophages kill Listeria? Our results, but also the published ones on IFN type II receptor- and iNOS-deficient mice, rather argue against RNI production being a limiting factor. ROI may be involved since ICSBP- and NF-IL6–deficient mice had reduced respiratory burst, and this correlated with high susceptibility to Listeria infection. But still there may be a potential third mechanism involved to explain the drastic phenotype of ICSBP−/− mice. Studies on iron metabolism of peritoneal macrophages (64) and murine β-thalassemia (65) suggested that iron scavengers lead to enhanced, and iron overload to reduced, resistance to Listeria by direct interference with the essential bacterial iron metabolism. Whether IFN-γ– and/or TNF-α–mediated enhancement of iron-binding proteins can explain resistance to murine listeriosis remains to be investigated.

Acknowledgments

We would like to thank A. Schaffner and H. Hengartner for expert advice and helpful discussion; C. Weissmann and M. Aguet for mutant mouse strains; J. Bille for anti-Listeria serum; A. Althage, L. Vlk, and H. Haber for excellent technical support; H. Neff and N. Wey for photographs; and E. Hörhager, and S. Kläusli for secretarial help.

This work was supported by the Swiss National Science Foundation grant no. 31-32195.91 to R.M. Zinkernagel, and grants no. 31-4577.95 and 32-42536.94 to G. Schoedon), the Kanton of Zürich and the German Science Foundation (DFG).

References

References
1
Kaufmann
SHE
Immunity to intracellular bacteria
Annu Rev Immunol
1993
11
129
163
[PubMed]
2
Conlan
JW
,
North
RJ
Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium
J Exp Med
1991
174
741
744
[PubMed]
3
Hiromatsu
K
,
Yoshikai
Y
,
Matsuzaki
G
,
Ohga
S
,
Muramori
K
,
Matsumoto
K
,
Bluestone
JA
,
Nomoto
K
A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice
J Exp Med
1992
175
49
56
[PubMed]
4
Bancroft
GJ
,
Schreiber
RD
,
Unanue
ER
Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse
Immunol Rev
1991
124
5
24
[PubMed]
5
Wherry
JC
,
Schreiber
RD
,
Unanue
ER
Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli
Infect Immun
1991
59
1709
1715
[PubMed]
6
Portnoy
DA
,
Schreiber
RD
,
Connelly
P
,
Tilney
LG
Gamma interferon limits access of Listeria monocytogenesto the macrophage cytoplasm
J Exp Med
1989
170
2141
2146
[PubMed]
7
Bancroft
GJ
,
Schreiber
RD
,
Bosma
GC
,
Bosma
MJ
,
Unanue
ER
A T cell-independent mechanism of macrophage activation by interferon-gamma
J Immunol
1987
139
1104
1107
[PubMed]
8
Mielke
MEA
,
Ehlers
S
,
Hahn
H
T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity
Infect Immun
1988
56
1920
1925
[PubMed]
9
Harty
JT
,
Schreiber
RD
,
Bevan
MJ
CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion
Proc Natl Acad Sci USA
1992
89
11612
11616
[PubMed]
10
Kägi
D
,
Ledermann
B
,
Bürki
K
,
Hengartner
H
,
Zinkernagel
RM
CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity
Eur J Immunol
1994
24
3068
3072
[PubMed]
11
Dalton
DK
,
Pitts-Meek
S
,
Keshav
S
,
Figari
IS
,
Bradley
A
,
Stewart
TA
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
Science (Wash DC)
1993
259
1739
1742
[PubMed]
12
Huang
S
,
Hendriks
W
,
Althage
A
,
Hemmi
S
,
Bluethmann
H
,
Kamijo
R
,
Vilcek
J
,
Zinkernagel
RM
,
Aguet
M
Immune response in mice that lack the interferon-gamma receptor [see comments]
Science (Wash DC)
1993
259
1742
1745
[PubMed]
13
Rothe
J
,
Lesslauer
W
,
Lotscher
H
,
Lang
Y
,
Koebel
P
,
Kontgen
F
,
Althage
A
,
Zinkernagel
R
,
Steinmetz
M
,
Bluethmann
H
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
Nature (Lond)
1993
364
798
802
[PubMed]
14
Lepay
DA
,
Steinman
RM
,
Nathan
CF
,
Murray
HW
,
Cohn
ZA
Liver macrophages in murine listeriosis
J Exp Med
1985
161
1503
1512
[PubMed]
15
Peck
R
Gamma interferon induces monocyte killing of Listeria monocytogenesby an oxygen-dependent pathway; alpha- or beta-interferons by oxygen-independent pathways
J Leukoc Biol
1989
46
434
440
[PubMed]
16
van Dissel
JT
,
Stikkelbroek
JJM
,
van Furth
R
Differences in the rate of intracellular killing of catalase-negative and catalase-positive Listeria moncytogenes by normal and interferon-gamma-activated macrophages
Scand J Immunol
1993
37
443
446
[PubMed]
17
Leenen
PJM
,
Canono
BP
,
Drevets
DA
,
Voerman
JSA
,
Campbell
PA
TNF-α and IFN-γ stimulate a macrophage precursor cell line to kill Listeria moncytogenes in a nitric oxide-independent manner
J Immunol
1994
154
5141
5147
18
Bläuer
F
,
Groscurth
P
,
Schneemann
M
,
Schoedon
G
,
Schaffner
A
Modulation of the antilisterial activity of human blood-derived macrophages by activating and deactivating cytokines
J Interferon Cytokine Res
1995
15
105
114
[PubMed]
19
Inoue
S
,
Itagaki
S-I
,
Amano
F
Intracellular killing of Listeria monocytogenes in the J774.1 macrophagelike cell line and the lipopolysaccharide (LPS)-resistant mutant LPS1916 cell line defective in the generation of reactive oxygen intermediates after LPS treatment
Infect Immun
1995
63
1876
1886
[PubMed]
20
Beckerman
KP
,
Rogers
HW
,
Corbett
JA
,
Schreiber
RD
,
McDaniel
ML
,
Unanue
ER
Release of nitric oxide during the T cell-independent pathway of macrophage activation
J Immunol
1993
150
888
895
[PubMed]
21
Flesch
IEA
,
Hess
JH
,
Kaufmann
SHE
NADPH diaphorase staining suggests a transient and localized contribution of nitric oxide to host defence against an intracellular pathogen in situ
Int Immunol
1994
6
1751
1757
[PubMed]
22
Boockvar
KS
,
Granger
DL
,
Poston
RM
,
Maybodi
M
,
Washington
MK
,
Hibbs
JB
Jr
,
Kurlander
RL
Nitric oxide produced during murine listeriosis is protective
Infect Immun
1994
62
1089
1100
[PubMed]
23
MacMicking
JD
,
Nathan
C
,
Hom
G
,
Chartrain
N
,
Fletcher
DS
,
Trumbauer
M
,
Stevens
K
,
Xie
Q-w
,
Sokol
K
,
Hutchinson
N
et al
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
Cell
1995
81
641
650
[PubMed]
24
Williams
BRG
Transcriptional regulation of interferon-stimulated genes
Eur J Biochem
1991
200
1
11
[PubMed]
25
Sen
GC
,
Lengyel
P
The interferon system; a bird's eye view of its biochemistry
J Biol Chem
1992
267
5017
5020
[PubMed]
26
Müller
U
,
Steinhoff
U
,
Reis
LF
,
Hemmi
S
,
Pavlovic
J
,
Zinkernagel
RM
,
Aguet
M
Functional role of type I and type II interferons in antiviral defense
Science (Wash DC)
1994
264
1918
1921
[PubMed]
27
van den Broek
MF
,
Müller
U
,
Huang
S
,
Aguet
M
,
Zinkernagel
RM
Antiviral defence in mice lacking both α/β and γ interferon receptors
J Virol
1995
69
4792
4796
[PubMed]
28
van den Broek
MF
,
Müller
U
,
Huang
S
,
Zinkernagel
RM
,
Aguet
M
Immune defence in mice lacking type I and/or type II interferon receptors
Immunol Rev
1995
148
5
18
[PubMed]
29
Levy
DE
,
Lew
DJ
,
Decker
T
,
Kessler
DS
,
Darnell
JE
Jr
Synergistc interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3
EMBO (Eur Mol Biol Organ) J
1990
9
1105
1111
[PubMed]
30
Coccia
EM
,
Marziali
G
,
Stellacci
E
,
Perrotti
E
,
Ilari
R
,
Orsatti
R
,
Battistini
A
Cells resistant to interferon-beta respond to interferon-gamma via the Stat1-IRF-1 pathway
Virology
1995
211
113
122
[PubMed]
31
Miyamoto
M
,
Fujita
T
,
Kimura
Y
,
Maruyama
M
,
Harada
H
,
Sudo
Y
,
Miyata
T
,
Taniguchi
T
Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements
Cell
1988
54
903
913
[PubMed]
32
Meraz
MA
,
White
JM
,
Sheehan
KCF
,
Bach
EA
,
Rodig
SJ
,
Dighe
AS
,
Kaplan
DH
,
Riley
JK
,
Greenlund
AC
,
Campbell
D
et al
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
Cell
1996
84
431
442
[PubMed]
33
Durbin
JE
,
Hackenmiller
R
,
Simon
MC
,
Levy
DE
Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
Cell
1996
84
443
450
[PubMed]
34
Driggers
PH
,
Ennist
DL
,
Gleason
SL
,
Mak
W-H
,
Marks
MS
,
Levi
B-Z
,
Flanagan
JR
,
Appella
E
,
Ozato
K
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes
Proc Natl Acad Sci USA
1990
87
3743
3747
[PubMed]
35
Politis
AD
,
Sivo
J
,
Driggers
PH
,
Ozato
K
,
Vogel
SN
Modulation of interferon consensus sequence binding protein mRNA in murine peritoneal macrophages
J Immunol
1992
148
801
807
[PubMed]
36
Holtschke
T
,
Löhler
J
,
Kanno
Y
,
Fehr
T
,
Giese
N
,
Rosenbauer
F
,
Lou
J
,
Knobeloch
K-P
,
Gabriele
L
,
Waring
JF
et al
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene
Cell
1996
87
307
317
[PubMed]
37
Harada
H
,
Fujita
T
,
Miyamoto
M
,
Kimura
Y
,
Maruyama
M
,
Furia
A
,
Miyata
T
,
Taniguchi
T
Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes
Cell
1989
58
729
739
[PubMed]
38
Nelson
N
,
Marks
MS
,
Driggers
PH
,
Ozato
K
Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferoninduced gene transcription
Mol Cell Biol
1993
13
588
599
[PubMed]
39
Matsuyama
T
,
Kimura
T
,
Kitagawa
M
,
Pfeffer
K
,
Kawakami
T
,
Watanabe
N
,
Kündig
TM
,
Amakawa
R
,
Kishihara
K
,
Wakeham
A
et al
Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development
Cell
1993
75
83
97
[PubMed]
40
Kimura
T
,
Nakayama
K
,
Penninger
J
,
Kitagawa
M
,
Harada
H
,
Matsuyama
T
,
Tanaka
N
,
Kamijo
R
,
Vilcek
J
,
Mak
TW
,
Taniguchi
T
Involvement of the IRF-1 transcription factor in antiviral responses to interferons
Science (Wash DC)
1994
264
1921
1923
[PubMed]
41
Schoedon
G
,
Schneemann
M
,
Hofer
S
,
Guerrero
L
,
Blau
N
,
Schaffner
A
Regulation of the L-argininedependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages
Eur J Biochem
1993
213
833
839
[PubMed]
42
Rellstab
P
,
Schaffner
A
Endotoxin suppresses the generation of O2- and H2O2by “resting” and lymphokine-activated human blood-derived macrophages
J Immunol
1989
142
2813
2820
[PubMed]
43
Schaffner
A
,
Rellstab
P
Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes
J Clin Invest
1988
82
913
919
[PubMed]
44
Bovolenta
C
,
Driggers
PH
,
Marks
MS
,
Medin
JA
,
Politis
AD
,
Vogel
SN
,
Levy
DE
,
Sakaguchi
K
,
Appella
E
,
Coligan
JE
et al
Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family
Proc Natl Acad Sci USA
1994
91
5046
5050
[PubMed]
45
Weisz
A
,
Kirchhoff
S
,
Levi
B-Z
IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters
Int Immunol
1994
6
1125
1131
[PubMed]
46
Emmerling
P
,
Finger
H
,
Hof
H
Cell-mediated resistance to infection with Listeria monocytogenes in nude mice
Infect Immun
1977
15
382
385
[PubMed]
47
Shinkai
Y
,
Rathbun
G
,
Lam
KP
,
Oltz
EM
,
Stewart
V
,
Mendelsohn
M
,
Charron
J
,
Datta
M
,
Young
F
,
Stall
AM
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
Cell
1992
68
855
867
[PubMed]
48
Kamijo
R
,
Harada
H
,
Matsuyama
T
,
Bosland
M
,
Gerecitano
J
,
Shapiro
D
,
Le
J
,
Koh
SI
,
Kimura
T
,
Green
SJ
et al
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
Science (Wash DC)
1994
263
1612
1615
[PubMed]
49
Martin
E
,
Nathan
C
,
Xie
Q-w
Role of interferon regulatory factor 1 in induction of nitric oxide synthase
J Exp Med
1994
180
977
984
[PubMed]
50
Kamijo
R
,
Shapiro
D
,
Le
J
,
Huang
S
,
Aguet
M
,
Vilcek
J
Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor
Proc Natl Acad Sci USA
1993
90
6626
6630
[PubMed]
51
Salkowski
CA
,
Barber
SA
,
Detore
GR
,
Vogel
SN
Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes
J Immunol
1996
157
3107
3110
[PubMed]
52
Berche
PA
Resistance to listeriosis in two lines of mice genetically selected for high and low antibody production
Immunology
1985
56
707
715
[PubMed]
53
Barber
SA
,
Fultz
MJ
,
Salkowski
CA
,
Vogel
SN
Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages
Infect Immun
1995
63
601
608
[PubMed]
54
Dabiri
GA
,
Sanger
JM
,
Portnoy
DA
,
Southwick
FS
Listeria monocytogenesmoves rapidly through the host-cell cytoplasm by inducing directional actin assembly
Proc Natl Acad Sci USA
1990
87
6068
6072
[PubMed]
55
Stenger
S
,
Thüring
H
,
Röllinghoff
M
,
Bogdan
C
Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.
J Exp Med
1994
180
783
793
[PubMed]
56
Wei
XQ
,
Charles
IG
,
Smith
A
,
Ure
J
,
Feng
GJ
,
Huang
FP
,
Xu
D
,
Muller
W
,
Moncada
S
,
Liew
FY
Altered immune responses in mice lacking inducible nitric oxide synthase
Nature (Lond)
1995
375
408
411
[PubMed]
57
Khan
IA
,
Matsuura
T
,
Fonseka
S
,
Kasper
LH
Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondiiinfection in IRF-1−/− mice
J Immunol
1996
156
636
643
[PubMed]
58
Samsom
JN
,
Langermans
JA
,
Groeneveld
PH
,
van Furth
R
Acquired resistance against a secondary infection with Listeriamonocytogenes in mice is not dependent on reactive nitrogen intermediates
Infect Immun
1996
64
1197
1202
[PubMed]
59
Gregory
SH
,
Wing
EJ
,
Hoffman
RA
,
Simmons
RL
Reactive nitrogen intermediates suppress the primary immunologic response to Listeria.
J Immunol
1993
150
2901
2909
[PubMed]
60
Aggarwal
BB
,
Eessalu
TE
,
Hass
PE
Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon
Nature (Lond)
1985
318
665
667
[PubMed]
61
Collart
MA
,
Belin
D
,
Vassalli
J-D
,
de Kossodo
S
,
Vassalli
P
Gamma-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors
J Exp Med
1986
164
2113
2118
[PubMed]
62
Akira
S
,
Yoshida
K
,
Tanaka
T
,
Taga
T
,
Kishimoto
T
Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6
Immunol Rev
1995
148
221
253
[PubMed]
63
Tanaka
T
,
Akira
S
,
Yoshida
K
,
Umemoto
M
,
Yoneda
Y
,
Shirafuji
N
,
Fujiwara
H
,
Suematsu
S
,
Yoshida
N
,
Kishimoto
T
Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages
Cell
1995
80
353
361
[PubMed]
64
Alford
CE
,
King
TE
Jr
,
Campbell
PA
Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity
J Exp Med
1991
174
459
466
[PubMed]
65
Ampel
NM
,
Van Wyck
DB
,
Aguirre
ML
,
Willis
DG
,
Popp
RA
Resistance to infection in murine beta-Thalassemia
Infect Immun
1989
57
1011
1017
[PubMed]
66
Lieschke
GJ
,
Grail
D
,
Hodgson
G
,
Metcalf
D
,
Stanley
E
,
Cheers
C
,
Fowler
KJ
,
Basu
S
,
Zhan
YF
,
Dunn
AR
Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization
Blood
1994
84
1737
1746
[PubMed]
67
Fujita
T
,
Reis
LF
,
Watanabe
N
,
Kimura
Y
,
Taniguchi
T
,
Vilcek
J
Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways
Proc Natl Acad Sci USA
1989
86
9936
9940
[PubMed]

1Abbreviations used in this paper: ICSBP, interferon consensus sequence binding protein; i.f., into the footpad; iNOS, inducible nitric oxide synthase; IRF1/2, interferon regulatory factor 1/2; ISGF, interferon-stimulated gene factor; ISRE, interferon-stimulated response element; NO, nitric oxide; PEM, peritoneal macrophage; RNI, reactive nitrogen intermediates; ROI, reactive oxygen intermediates; STAT, signal transducers and activators of transcription.

Author notes

Address correspondence to Thomas Fehr, Institute of Experimental Immunology, University Hospital, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland.